Matthew Fornataro

Partner at Arnold & Porter

Speaker

Matt Fornataro's practice focuses on life sciences and health care regulation, litigation, and public policy matters. Matt specializes in drug pricing and government price reporting, pharmaceutical market access strategies and contracting, and fraud and abuse compliance. He supports his clients on cutting-edge drug pricing matters, including recent Most Favored Nation initiatives and the Medicare Maximum Fair Price program. Alongside this work, Matt advises manufacturers on fraud and abuse compliance and customer contracting across the pharmaceutical supply chain and coverage landscape. Matt assists manufacturers with complex risk analyses, internal reviews and investigations, OIG Advisory Opinion requests, product acquisitions and divestitures, government audits and investigations, and Congressional inquiries.